These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9379021)

  • 21. Monocyte-driven activation-induced apoptotic cell death of human T-lymphotropic virus type I-infected T cells.
    Wakamatsu S; Makino M; Tei C; Baba M
    J Immunol; 1999 Oct; 163(7):3914-9. PubMed ID: 10490992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
    Zhang J; Cado D; Chen A; Kabra NH; Winoto A
    Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential susceptibility to CD95 (Apo-1/Fas) and MHC class II-induced apoptosis during murine dendritic cell development.
    McLellan AD; Terbeck G; Mengling T; Starling GC; Kiener PA; Gold R; Bröcker EB; Leverkus M; Kämpgen E
    Cell Death Differ; 2000 Oct; 7(10):933-8. PubMed ID: 11279539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis.
    Di Somma MM; Somma F; Gilardini Montani MS; Mangiacasale R; Cundari E; Piccolella E
    J Immunol; 1999 Apr; 162(7):3851-8. PubMed ID: 10201902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic preparations of normal polyspecific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIg involving the Fas apoptotic pathway.
    Prasad NK; Papoff G; Zeuner A; Bonnin E; Kazatchkine MD; Ruberti G; Kaveri SV
    J Immunol; 1998 Oct; 161(7):3781-90. PubMed ID: 9759905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The TCR-binding region of the HLA class I alpha2 domain signals rapid Fas-independent cell death: a direct pathway for T cell-mediated killing of target cells?
    Pettersen RD; Gaudernack G; Olafsen MK; Lie SO; Hestdal K
    J Immunol; 1998 May; 160(9):4343-52. PubMed ID: 9574538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
    Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
    Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro thymocyte maturation is associated with reduced cellular susceptibility to Fas-mediated apoptosis.
    Hershberger PA; He H; McCarthy SA
    Cell Immunol; 1998 May; 185(2):134-45. PubMed ID: 9636691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fas/Fas ligand signaling during gestational T cell development.
    Fleck M; Zhou T; Tatsuta T; Yang P; Wang Z; Mountz JD
    J Immunol; 1998 Apr; 160(8):3766-75. PubMed ID: 9558079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD47 signals T cell death.
    Pettersen RD; Hestdal K; Olafsen MK; Lie SO; Lindberg FP
    J Immunol; 1999 Jun; 162(12):7031-40. PubMed ID: 10358145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells.
    Matsue H; Edelbaum D; Hartmann AC; Morita A; Bergstresser PR; Yagita H; Okumura K; Takashima A
    J Immunol; 1999 May; 162(9):5287-98. PubMed ID: 10228004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
    Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility to Fas and tumor necrosis factor-alpha receptor mediated apoptosis of anti-CD3/anti-CD28-activated umbilical cord blood T cells.
    Lin SJ; Lee CC; Cheng PJ; See LC; Kuo ML
    Pediatr Allergy Immunol; 2009 Jun; 20(4):392-8. PubMed ID: 18713315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of susceptibility of mature human T lymphocytes to dexamethasone-induced apoptosis.
    Tuosto L; Cundari E; Gilardini Montani MS; Piccolella E
    Eur J Immunol; 1994 May; 24(5):1061-5. PubMed ID: 8181517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the thymocyte cell cycle by bivariate analysis of incorporated bromodeoxyuridine and DNA content.
    Baron C; Pénit C
    Eur J Immunol; 1990 Jun; 20(6):1231-6. PubMed ID: 2369916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis induced by serum deprivation of PC12 cells is not preceded by growth arrest and can occur at each phase of the cell cycle.
    Lindenboim L; Diamond R; Rothenberg E; Stein R
    Cancer Res; 1995 Mar; 55(6):1242-7. PubMed ID: 7533660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle.
    Cotter TG; Glynn JM; Echeverri F; Green DR
    Anticancer Res; 1992; 12(3):773-9. PubMed ID: 1622137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.